Clinical trials
Phase 3 Hemophilia A trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Active, not recruiting | 6 |
| Recruiting | 4 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 12 |
| Hoffmann-La Roche | 8 |
| Baxalta now part of Shire | 7 |
| Pfizer | 5 |
| Bioverativ, a Sanofi company | 4 |
| Genzyme, a Sanofi Company | 4 |
| Octapharma | 4 |
| Bio Products Laboratory | 3 |
| Bioverativ Therapeutics Inc. | 3 |
| Bayer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 58 |
| Hemophilia B | 8 |
| Blood Coagulation Disorders | 7 |
| Coagulation Protein Disorders | 6 |
| Hematologic Diseases | 6 |
| Hemorrhagic Disorders | 5 |
| Blood Coagulation Disorders, Inherited | 4 |
| Genetic Diseases, Inborn | 4 |
| Genetic Diseases, X-Linked | 3 |
| Hemorrhage | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.